Journal of International Medical Research · 2019 · 12 citations · 14 references
MedicineHematologyOncologyCancer GeneticsHematologic OncologyHematopathologyBone Marrow EvaluationBone Marrow PathologyCancer BiomarkersCancer Survival AnalysisCell CharacterizationHematologic MalignanciesAcute LeukemiasAcute Lymphoblastic Leukemia TreatmentAcute Myeloid Leukemia TherapyAcute Myeloid Leukemia TreatmentBcr-abl1 Fusion GeneFlow Cytometry ImmunophenotypingFusion Gene BiomarkersKaplan-meier Confidence Intervals
OBJECTIVES: Acute leukemia (AL) is a highly heterogeneous malignant disease caused by hematopoietic cell abnormalities. Our study investigated the potential for immunophenotyping of leukemic cells via flow cytometry and the clinical usefulness of this approach in treatment of AL. METHODS: Bone marrow (BM) specimens were collected to detect antigen expression on hematopoietic cells in pre-treatment samples from patients with AL. In addition, fraction survival curves were calculated using the Kaplan-Meier method to explore the effect of markers on prognosis in AL. RESULTS: Expression levels of immunophenotypic markers in patients with acute lymphoblastic leukemia (ALL) were significantly different from those in patients with acute myeloid leukemia (AML). In addition, there was a potential association between the surface marker, cluster of differentiation 2 (CD2), and fraction survival in AML. However, no similar result was found in ALL. Moreover, genetic tests showed greater positive variation of the break point cluster-Abelson tyrosine kinase ( BCR-ABL) fusion gene in samples from patients with ALL than in samples from patients with AML. CONCLUSIONS: We have shown a rapid and effective flow cytometry method that enables the identification of immunophenotype in AL. Moreover, CD2 may constitute a predictive marker for prognosis in patients with AML.
14
John M. Bennett, Daniel Catovsky, Marie‐Theregse Daniel et al. · British Journal of Haematology · 1976 · 5.6K citations
Medicine, Hematology, Pathology +17
Berend Snijder, Gregory I. Vladimer, Nikolaus Krall et al. · The Lancet Haematology · 2017 · 182 citations · Full text
Medicine, Oncology, Pharmacology +15
Adhra Al‐Mawali, David Gillis, Pravin Hissaria et al. · American Journal of Clinical Pathology · 2008 · 103 citations
Medicine, Hematology, Oncology +16
Wendelien Zeijlemaker, Angèle Kelder, Yvonne J.M Oussoren-Brockhoff et al. · Leukemia · 2015 · 85 citations · Full text
Medicine, Hematology, Oncology +17